Siu-Long Yao

Title: Siu-Long Yao: Innovator in Medical Treatments

Introduction

Siu-Long Yao is a prominent inventor based in West Windsor, NJ (US). He has made significant contributions to the field of medical treatments, particularly in addressing disorders related to genetic mutations. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

One of Siu-Long Yao's latest patents is titled "Methods for treatment of polyposis." This invention focuses on treating medical disorders mediated by mutations in the APC gene by administering an IGF1R inhibitor. Such disorders include familial adenomatous polyposis (FAP). Another notable patent is "FDG-pet evaluation of Ewing's sarcoma sensitivity." This invention relates to methods for evaluating the efficacy of an IGF1R inhibitor, such as an anti-IGF1R antibody, for the treatment of Ewing's sarcoma tumors. It involves determining the level of tumoral glucose metabolism at an early point in the treatment regimen using methods like FDG-PET/CT scans.

Career Highlights

Siu-Long Yao is currently associated with Merck Sharp & Dohme Corp., where he continues to innovate and develop new medical treatments. His expertise in the field has led to advancements that could change the landscape of treatment for various medical conditions.

Collaborations

Throughout his career, Siu-Long Yao has collaborated with notable colleagues, including Brian DerHua Lu and Cynthia Seidel-Dugan. These partnerships have fostered an environment of innovation and shared knowledge, contributing to the success of their projects.

Conclusion

Siu-Long Yao's work exemplifies the spirit of innovation in the medical field. His patents and collaborations highlight his commitment to improving treatment options for patients with genetic disorders. His contributions are paving the way for future advancements in medical science.